Insider Trading is Good News for These Stocks

INSIDER TRADING text written on a notebook with chart

Key Points

  • Perspective Therapeutics' major shareholder doubled down on the position, validating the business and pipeline. 
  • Liberty Live Group's SiriusXM stock is bought by Warren Buffett and Berkshire Hathaway. 
  • NB Bancorp is an aged institution that recently IPOd with great success; it is still undervalued. 

The threat of fines and imprisonment, up to twenty years for the worst offenders, makes insider trading a different game than what it was. Today, insiders must reveal their trading within days of execution or face the fullest extent of the law. Savvy investors can use those filings to uncover hot trades and follow the leader to investment success; Insidertrades.com tracks those trades, so you don’t have to. This article highlights the top three stocks insiders bought over a 90-day look-back period; all are moving higher and have ample upside potential. 

A Major Shareholder Doubles-Down on Perspective Therapeutics

Perspective Therapeutics (NYSE: CATX) focuses on targeted alpha oncology therapies. It has several therapies in late-stage clinical trials, a partnership to develop therapies with Bristol-Meyers Squibb (NYSE: BMY), and a major shareholder recently doubled down on their holdings. Lantheus Holdings (NASDAQ: LNTH) is a major developer, manufacturer, and distributor of medical diagnostic and therapeutic products worldwide. It purchased roughly 60 million shares, nearly doubling its position bringing the stake to nearly 20%. This is a significant increase in ownership and validation of the business and pipeline. Perspective Therapeutics is the most bought by insiders by share count. 


Top-Secret Government Project Revealed
Details a top-secret program for taking America’s most critical technology mainstream. And it has nothing to do with artificial intelligence, cryptocurrency, or the blockchain.
To get all the details of this new tech – click here now.


Market support for Perspective Therapeutics is strong. Insidertrades.com tracks six analysts that peg the stock with a consensus Buy rating. The Buy rating has been steady for the last year, but the price target is increasing. The price target revisions lifted the consensus target by 50% in twelve months, with recent activity at the high end of the range. The freshest target is the highest on Wall Street; the Royal Bank of Canada set it and projects a price of $3.00 or nearly 100% upside. Coincidentally, the most-bought stock by dollar value is also a pharma company that was recently bought out.

CATX stock chart

Liberty Live Group has a Friend in Warren Buffett 

Liberty Live Group (NASDAQ: LLYVA) is a complex media company with assets including Formula One (NASDAQ: FWONK) and SiriusXM Radio (NASDAQ: LSXMA). The stock structure is more complex, with at least nine tracking stocks to cover the different business aspects with voting and non-voting rights.

Today’s takeaway is that Berkshire Hathaway (NYSE: BRK-A) owns seven. The positions are high double-digit stakes in most cases, and the firm has been adding to the bulk position this year. The target appears to be SiriusXM, but Liberty Live and Formula One are in the mix. 

Analysts are bullish on the group. However, shares of Sirius Series A and C (NASDAQ: LSXMK), the ones most bought by Berkshire, are the most undervalued. Insidertrades.com tracks four analysts with a Moderate Buy rating and a $37.65 price target. That target implies a 55% upside for the stock, putting it at a multi-year high and in full reversal. A move to that level would be bullish and open the door to another $12 of upside. 

NB Bancorp is an Aged Institution With Lots of Value

NB Bancorp (NASDAQ: NBBK) has been in business for over 130 years, offering financial services in Massachusetts and surrounding areas—the company only recently IPOd, seeking capital to finance targeted growth opportunities. The IPO was well-received and oversubscribed, leading to a meteoric rise in the share prices. Trading at $15.95, the stock is nearly 15% above its IPO price and still undervalued. The company’s tangible book is near $17.30, suggesting another 9% upside is the minimum to expect.

Insiders are buying this stock and not just one or two. Seven insiders, including several board members, the CEO, CFO, COO, and EVP, made eleven transactions in the look-back window, making this the most bought stock by activity. They own 1.7% of the stock, and institutional ownership is also rising. Institutions, including the bank’s employee benefit plan, own about 30% of the stock, and their buying accelerated from Q1 to Q2, providing a tailwind for the market. Only one analyst has a rating tracked by Insidertrades.com, but it’s a Buy with a price target above the current action. 

NBBK stock chart

Insider Buying or Selling at Perspective Therapeutics?
Sign-up to receive InsiderTrades.com's daily insider buying and selling report for Perspective Therapeutics and related companies.

Companies in This Article:

CompanyCurrent PricePrice ChangeDividend YieldP/E RatioConsensus RatingConsensus Price Target
Bristol-Myers Squibb (BMY)$41.20-0.7%5.83%-13.29Hold$60.00
The Liberty SiriusXM Group (LSXMA)$21.05+2.8%N/A8.66Moderate Buy$37.67
The Liberty SiriusXM Group (LSXMK)$20.94+2.7%N/A8.62Moderate Buy$36.00
Formula One Group (FWONK)$72.43+1.1%N/A52.87Moderate Buy$84.00
Formula One Group (FWONA)$65.43+1.1%N/A47.76Buy$77.00
NB Bancorp (NBBK)$14.57-0.1%N/AN/ABuy$17.00
Perspective Therapeutics (CATX)$1.08-6.9%N/AN/ABuy$1.90
Lantheus (LNTH)$79.26-1.0%N/A12.10Moderate Buy$99.17
Berkshire Hathaway (BRK-A)$610,900.00-0.1%N/AN/AN/A
Thomas Hughes

About Thomas Hughes

Experience

Thomas Hughes has been a contributing writer for InsiderTrades.com since 2019.

Areas of Expertise

Technical analysis, the S&P 500; retail, consumer, consumer staples, dividends, high-yield, small caps, technology, economic data, oil, cryptocurrencies

Education

Associate of Arts in Culinary Technology

Past Experience

Market watcher, trader and investor for numerous websites. Founded Passive Market Intelligence LLC to provide market research insights. 

Free Insider Buying and Selling Newsletter
Enter your email address below to receive InsiderTrades.com's daily insider buying and selling report.
From Our Partners

Most Read This Month

Recent Articles